Biotest Aktiengesellschaft (ETR:BIO3)

ETR:BIO3 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,444	1,349	1,456	1,520	1,609	1,126
Market Cap Growth	2.60%	-7.34%	-4.17%	-5.54%	42.88%	43.33%
Enterprise Value	2,071	1,939	2,087	2,013	2,034	1,521
Last Close Price	30.00	27.00	30.91	33.90	38.45	27.95
PE Ratio	-	51.11	11.47	-	-	-
Forward PE	19.97	24.51	-	-	-	-
PS Ratio	2.27	1.86	2.13	2.94	3.12	2.33
PB Ratio	2.83	2.54	2.92	4.10	4.23	2.55
P/TBV Ratio	2.93	2.58	2.97	4.20	4.35	2.62
P/FCF Ratio	-	41.91	-	-	103.11	-
P/OCF Ratio	100.30	22.16	-	-	47.59	-
EV/Sales Ratio	3.26	2.67	3.05	3.90	3.95	3.14
EV/EBITDA Ratio	42.29	16.06	14.19	193.51	-	87.93
EV/EBIT Ratio	272.53	22.33	17.88	-	-	-
EV/FCF Ratio	-144.84	60.21	-	-	130.42	-
Debt / Equity Ratio	1.31	1.27	1.38	1.74	1.40	1.11
Debt / EBITDA Ratio	12.53	5.28	4.52	41.29	-	22.09
Debt / FCF Ratio	-	20.86	-	-	34.05	-
Asset Turnover	0.44	0.51	0.52	0.45	0.46	0.43
Inventory Turnover	1.01	1.12	1.13	1.45	1.63	1.24
Quick Ratio	1.49	2.04	0.84	2.37	2.52	2.49
Current Ratio	4.93	5.06	1.96	4.76	4.91	5.27
Return on Equity (ROE)	-4.72%	5.13%	29.20%	-8.44%	-15.43%	-6.84%
Return on Assets (ROA)	0.52%	3.81%	5.58%	-1.09%	-2.85%	-0.42%
Return on Capital (ROIC)	0.63%	4.54%	6.62%	-1.31%	-3.45%	-0.52%
Return on Capital Employed (ROCE)	1.00%	6.80%	11.40%	-	-	-
Earnings Yield	-1.70%	1.96%	8.72%	-2.09%	-3.94%	-2.79%
FCF Yield	-0.99%	2.39%	-2.48%	-4.59%	0.97%	-3.88%
Dividend Yield	0.13%	0.15%	0.13%	-	0.10%	0.14%
Payout Ratio	-	6.06%	-	-	-	-
Total Shareholder Return	1.59%	0.15%	0.13%	-	0.10%	0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.